Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis

Lúcia Moreira-Teixeira(The Francis Crick Institute), Philippa J. Stimpson(The Francis Crick Institute), Evangelos Stavropoulos(The Francis Crick Institute), Sabelo Hadebe(The Francis Crick Institute), Probir Chakravarty(The Francis Crick Institute), Μαριάννα Ιωάννου(The Francis Crick Institute), Iker Valle Aramburu(The Francis Crick Institute), Eleanor Herbert(Royal Veterinary College), Simon L. Priestnall(Royal Veterinary College), Alejandro Suárez‐Bonnet(Royal Veterinary College), Jeremy Sousa(Universidade do Porto), Kaori L. Fonseca(Universidade do Porto), Qian Wang(The Francis Crick Institute), Sergo Vashakidze(National Center for Tuberculosis and Lung Disease), Paula Rodríguez‐Martínez(Universitat Autònoma de Barcelona), Cristina Vilaplana(Universitat Autònoma de Barcelona), Margarida Saraiva(Universidade do Porto), Venizelos Papayannopoulos(The Francis Crick Institute), Anne O’Garra(Imperial College London)
Nature Communications
November 4, 2020
Cited by 226Open Access
Full Text

Abstract

Tuberculosis (TB) is a leading cause of mortality due to infectious disease, but the factors determining disease progression are unclear. Transcriptional signatures associated with type I IFN signalling and neutrophilic inflammation were shown to correlate with disease severity in mouse models of TB. Here we show that similar transcriptional signatures correlate with increased bacterial loads and exacerbate pathology during Mycobacterium tuberculosis infection upon GM-CSF blockade. Loss of GM-CSF signalling or genetic susceptibility to TB (C3HeB/FeJ mice) result in type I IFN-induced neutrophil extracellular trap (NET) formation that promotes bacterial growth and promotes disease severity. Consistently, NETs are present in necrotic lung lesions of TB patients responding poorly to antibiotic therapy, supporting the role of NETs in a late stage of TB pathogenesis. Our findings reveal an important cytokine-based innate immune effector network with a central role in determining the outcome of M. tuberculosis infection.


Related Papers

No related papers found

Powered by citation graph analysis